IT Professional Services Market in EMEA 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	16 Pages	TechNavio	October, 2023	INF18272866

Best Price Guarantee
Price	from $2,500
Length	16 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18272866

Global IT Professional Services Market 2024-2028

The IT professional services market is forecasted to grow by USD 167.43 billion during 2023-2028, accelerating at a CAGR of 8.74% during the forecast period. The report on the it professional services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust adoption of cloud-based solutions, growth in e-commerce and online services, and growing demand for IT professional services in healthcare sector.

Technavio's it professional services market is segmented as below:

By Type

Project-oriented services
Information technology outsourcing
IT supporting and training services
Enterprise cloud computing services

By End-user

Large enterprises
Small
medium enterprises

By Geographical Landscape

EMEA

This study identifies the digital transformation as one of the prime reasons driving the IT professional services market growth during the next few years. Also, advances in technology and increasing adoption of e-governance will lead to sizable demand in the market.

The report on the it professional services market covers the following areas:

IT professional services market sizing
IT professional services market forecast
IT professional services market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading it professional services market vendors that include Accenture Plc, Amadeus IT Group SA, Amazon.com Inc., Atos SE, Capgemini Service SAS, Dassault Systemes SE, Datto Holdings Corp., Deloitte Touche Tohmatsu Ltd., DXC Technology Co., Fujitsu Ltd., HCL Technologies Ltd., Hewlett Packard Enterprise Co., Hexagon AB, Infosys Ltd., International Business Machines Corp., Microsoft Corp., Oracle Corp., SAP SE, Siemens AG, and Tata Consultancy Services Ltd.. Also, the IT professional services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Cushing syndrome market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global cushing syndrome market 2018 - 2022 ($ million); 4.2 Type Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2023-2028 (%); Exhibit 31: Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 Glucocorticoid receptor antagonists - Market size and forecast 2023-2028; Exhibit 34: Chart on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%); 6.4 Pituitary directed drugs - Market size and forecast 2023-2028; Exhibit 38: Chart on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Pituitary directed drugs - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Pituitary directed drugs - Year-over-year growth 2023-2028 (%); 6.5 Steroidogenesis inhibitors - Market size and forecast 2023-2028; Exhibit 42: Chart on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Type; Exhibit 46: Market opportunity by Type ($ million); Exhibit 47: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%); 7.2 Comparison by Distribution Channel; Exhibit 50: Chart on Comparison by Distribution Channel; Exhibit 51: Data Table on Comparison by Distribution Channel; 7.3 Hospital pharmacy - Market size and forecast 2023-2028; Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); 7.4 Retail pharmacy - Market size and forecast 2023-2028; Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); 7.5 Online pharmacy - Market size and forecast 2023-2028; Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Distribution Channel; Exhibit 64: Market opportunity by Distribution Channel ($ million); Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Corcept Therapeutics Inc.; Exhibit 115: Corcept Therapeutics Inc. - Overview; Exhibit 116: Corcept Therapeutics Inc. - Product / Service; Exhibit 117: Corcept Therapeutics Inc. - Key offerings; 12.4 Perrigo Co. Plc; Exhibit 118: Perrigo Co. Plc - Overview; Exhibit 119: Perrigo Co. Plc - Business segments; Exhibit 120: Perrigo Co. Plc - Key news; Exhibit 121: Perrigo Co. Plc - Key offerings; Exhibit 122: Perrigo Co. Plc - Segment focus; 12.5 Recordati S.p.A; Exhibit 123: Recordati S.p.A - Overview; Exhibit 124: Recordati S.p.A - Business segments; Exhibit 125: Recordati S.p.A - Key offerings; Exhibit 126: Recordati S.p.A - Segment focus; 12.6 Xeris Biopharma Holdings Inc.; Exhibit 127: Xeris Biopharma Holdings Inc. - Overview; Exhibit 128: Xeris Biopharma Holdings Inc. - Product / Service; Exhibit 129: Xeris Biopharma Holdings Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 130: Inclusions checklist; Exhibit 131: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 132: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 133: Research methodology; Exhibit 134: Validation techniques employed for market sizing; Exhibit 135: Information sources; 13.5 List of abbreviations; Exhibit 136: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global cushing syndrome market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Type - Market share 2023-2028 (%); Exhibits31: Data Table on Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Pituitary directed drugs - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Pituitary directed drugs - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Type ($ million); Exhibits47: Data Table on Market opportunity by Type ($ million); Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Distribution Channel; Exhibits51: Data Table on Comparison by Distribution Channel; Exhibits52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Distribution Channel ($ million); Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Corcept Therapeutics Inc. - Overview; Exhibits116: Corcept Therapeutics Inc. - Product / Service; Exhibits117: Corcept Therapeutics Inc. - Key offerings; Exhibits118: Perrigo Co. Plc - Overview; Exhibits119: Perrigo Co. Plc - Business segments; Exhibits120: Perrigo Co. Plc - Key news; Exhibits121: Perrigo Co. Plc - Key offerings; Exhibits122: Perrigo Co. Plc - Segment focus; Exhibits123: Recordati S.p.A - Overview; Exhibits124: Recordati S.p.A - Business segments; Exhibits125: Recordati S.p.A - Key offerings; Exhibits126: Recordati S.p.A - Segment focus; Exhibits127: Xeris Biopharma Holdings Inc. - Overview; Exhibits128: Xeris Biopharma Holdings Inc. - Product / Service; Exhibits129: Xeris Biopharma Holdings Inc. - Key offerings; Exhibits130: Inclusions checklist; Exhibits131: Exclusions checklist; Exhibits132: Currency conversion rates for US$; Exhibits133: Research methodology; Exhibits134: Validation techniques employed for market sizing; Exhibits135: Information sources; Exhibits136: List of abbreviations